GWPHARM
GW Pharma Limited
Application Filed: 2014-06-05
Trademark Application Details
ABANDONED - AFTER INTER-PARTES DECISION
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79154002 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Michelle L. Visser |
| Attorney Name | Michelle L. Visser |
| Attorney Docket Number | 66569-0042 |
| Law Office Assigned | N10 |
| Employee Name | FAIRBANKS, RONALD L |
Timeline
| 2014-06-05 | Application Filed |
| 2015-02-17 | Published for Opposition |
| 2015-10-13 | Abandon |
| 2015-10-13 | Location: TTAB |
| 2015-10-13 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  GW Pharma Limited |
| Entity Statement | Private Limited Company |
| Address | Sovereign House, Histon Cambridge CB24 9BZ GB |
| Legal Entity Type | |
| Legal Entity State | GB |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; veterinary preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, spasticity, convulsions, seizures, epilepsy, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, obesity, obesity associated with diabetes; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, perioperative-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; pure extracts of medicinal plants and herbs for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposes |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2014-10-30 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2014-11-04 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2014-11-04 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2014-11-04 | 4 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2014-11-05 | 5 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2014-11-06 | 6 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2014-11-06 | 7 RFCS P: |
| APPLICATION FILING RECEIPT MAILED | 2014-11-08 | 8 MAFR O:Outgoing Correspondence |
| REFUSAL PROCESSED BY IB | 2014-11-21 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2014-11-22 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2014-11-22 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2014-11-22 | 12 TEME I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2014-11-25 | 13 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2014-11-25 | 14 ARAA I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2014-12-21 | 15 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2015-01-12 | 16 ALIE A:Allowance for Publication |
| ASSIGNED TO LIE | 2015-01-12 | 17 ALIE A:Allowance for Publication |
| ASSIGNED TO LIE | 2015-01-14 | 18 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2015-01-14 | 19 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2015-01-28 | 20 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2015-01-28 | 21 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2015-01-28 | 22 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2015-02-14 | 23 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2015-02-17 | 24 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2015-02-17 | 25 NPUB E:E-Mail |
| OPPOSITION PAPERS RECEIVED AT TTAB | 2015-03-19 | 26 OPPF T:TTAB Proceeding |
| OPPOSITION NOTICE (IB REFUSAL) CREATED | 2015-03-20 | 27 OPNC E:E-Mail |
| OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | 2015-03-20 | 28 OPNS B: |
| OPPOSITION INSTITUTED NO. 999999 | 2015-03-23 | 29 OP.I T:TTAB Proceeding |
| REFUSAL PROCESSED BY IB | 2015-04-24 | 30 RFNP P: |
| CHANGE OF NAME/ADDRESS REC'D FROM IB | 2015-06-19 | 31 ADCH M: |
| OPPOSITION SUSTAINED NO. 999999 | 2015-10-13 | 32 OP.S T:TTAB Proceeding |
| OPPOSITION TERMINATED NO. 999999 | 2015-10-13 | 33 OP.T T:TTAB Proceeding |
| ABANDONMENT - AFTER INTER PARTES DECISION | 2015-10-13 | 34 ABN4 O:Outgoing Correspondence |
| ABANDONMENT NOTICE MAILED - INTER PARTES DECISION | 2015-10-13 | 35 MAB4 O:Outgoing Correspondence |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2016-10-13 | 36 FICR P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2016-10-13 | 37 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2016-10-28 | 38 FINT P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2017-12-21 | 39 NREP P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2021-11-20 | 40 NREP P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 